MeSH term
Frequency | Condition_Probility | Animals | 31 | 0.0 |
Humans | 78 | 0.0 |
Mice | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 32 | 0.0 |
Biotransformation | 2 | 0.0 |
Cytochrome P-450 Enzyme System/*metabolism | 6 | 1.0 |
Isoenzymes/metabolism | 3 | 0.0 |
Oxidation-Reduction | 9 | 0.0 |
Recombinant Proteins/metabolism | 5 | 0.0 |
Spectrophotometry, Ultraviolet | 2 | 1.0 |
Substrate Specificity | 9 | 0.0 |
Continental Population Groups | 2 | 1.0 |
Gene Frequency | 5 | 0.0 |
Phenotype | 8 | 0.0 |
Polymorphism, Genetic/*genetics | 4 | 0.0 |
Adult | 18 | 0.0 |
Liver/enzymology | 5 | 0.0 |
Methylamines/metabolism | 3 | 15.0 |
Microsomes, Liver/drug effects/enzymology | 2 | 2.0 |
Middle Aged | 9 | 0.0 |
Oxygenases/*antagonists & inhibitors/metabolism | 2 | 100.0 |
Ranitidine/metabolism | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 38 | 0.0 |
Adolescent | 4 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 4 | 0.0 |
Female | 18 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Infant | 2 | 0.0 |
Male | 22 | 0.0 |
Microsomes, Liver/enzymology | 7 | 3.0 |
Oxygenases/genetics/*metabolism | 5 | 55.0 |
Cytochrome P-450 Enzyme System/metabolism | 2 | 0.0 |
Pharmaceutical Preparations/*metabolism | 2 | 2.0 |
Amino Acid Sequence | 14 | 0.0 |
Base Sequence | 15 | 0.0 |
Comparative Study | 11 | 0.0 |
DNA, Complementary/isolation & purification | 2 | 1.0 |
Dogs | 6 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Rabbits | 8 | 0.0 |
Rats | 12 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Swine | 4 | 0.0 |
European Continental Ancestry Group/*genetics | 3 | 0.0 |
Genotype | 12 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Oxygenases/*genetics/metabolism | 9 | 81.0 |
Stereoisomerism | 4 | 1.0 |
Alleles | 7 | 0.0 |
DNA Primers | 7 | 0.0 |
Haplotypes | 3 | 0.0 |
Oxygenases/*genetics | 10 | 41.0 |
Spectrum Analysis, Mass | 3 | 0.0 |
Cells, Cultured | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Oxygenases/*metabolism | 13 | 54.0 |
Canada | 2 | 1.0 |
Codon | 2 | 0.0 |
*Mutation | 5 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Quebec | 2 | 3.0 |
Sex Factors | 2 | 0.0 |
Exons | 5 | 0.0 |
Methylamines/*urine | 9 | 90.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Metabolism, Inborn Errors/*genetics | 2 | 8.0 |
Mutation, Missense/*genetics | 2 | 1.0 |
Odors | 4 | 25.0 |
Pedigree | 3 | 0.0 |
Syndrome | 4 | 0.0 |
Anti-Inflammatory Agents, Non-Steroidal/metabolism | 2 | 25.0 |
In Vitro | 11 | 0.0 |
Cytochrome P-450 Enzyme System/antagonists & inhibitors/*metabolism | 2 | 1.0 |
Enzyme Inhibitors/pharmacology | 6 | 0.0 |
Histamine H2 Antagonists/metabolism | 2 | 100.0 |
Methimazole/pharmacology | 2 | 15.0 |
Microsomes, Liver/metabolism | 3 | 1.0 |
Rats, Sprague-Dawley | 4 | 0.0 |
Microsomes, Liver/enzymology/metabolism | 2 | 3.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Hydrogen-Ion Concentration | 5 | 0.0 |
Time Factors | 3 | 0.0 |
Amino Acid Substitution/genetics | 2 | 0.0 |
*Odors | 2 | 28.0 |
Threonine/genetics | 2 | 2.0 |
Immunoblotting | 3 | 0.0 |
Kinetics | 10 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Korea | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
DNA, Complementary/biosynthesis | 2 | 3.0 |
Species Specificity | 4 | 0.0 |
Insects | 4 | 2.0 |
Cloning, Molecular | 7 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Flavin-Adenine Dinucleotide/metabolism | 2 | 9.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Clozapine/*pharmacokinetics | 2 | 50.0 |
Diet | 2 | 0.0 |
Metabolism, Inborn Errors/*genetics/urine | 2 | 66.0 |
Mutation | 3 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Microsomes, Liver/*enzymology | 7 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Microsomes/*enzymology | 2 | 4.0 |
Sex Characteristics | 3 | 0.0 |
Isoenzymes/chemistry/metabolism | 2 | 7.0 |
Liver/embryology/enzymology | 2 | 11.0 |
Methylamines/*metabolism | 2 | 66.0 |
Amines/pharmacology | 2 | 14.0 |
Methimazole/metabolism | 5 | 83.0 |
*Alternative Splicing | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Metabolism, Inborn Errors/*genetics/*urine | 2 | 100.0 |
Oxygenases/*genetics/*physiology | 2 | 100.0 |
Oxygenases/*chemistry | 2 | 100.0 |
Introns | 2 | 0.0 |
Catalysis | 3 | 0.0 |
Escherichia coli/genetics | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Oxygenases/chemistry/*genetics | 4 | 100.0 |
Genetic Vectors | 2 | 0.0 |
Guinea Pigs | 2 | 0.0 |
Microsomes/metabolism | 2 | 1.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
*Multigene Family | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Hepatocytes/*enzymology | 2 | 13.0 |
Microsomes, Liver | 2 | 20.0 |
Hydroxylation | 2 | 0.0 |